Publication & Citation Trends
Publications
0 total
The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies OA
Cited by 39
Semantic Scholar
A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.
Cited by 4
Semantic Scholar
The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
Cited by 91
Semantic Scholar
Abstract 4770: Anti-ROR1 monoclonal antibodies induce apoptosis in pancreatic cancer cells via the PI3-kinase/AKT/mTOR pathway
Cited by 5
Semantic Scholar
Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells OA
Cited by 8
Semantic Scholar
A Proline/Arginine-Rich End Leucine-Rich Repeat Protein (PRELP) Variant Is Uniquely Expressed in Chronic Lymphocytic Leukemia Cells OA
Cited by 14
Semantic Scholar
Towards New Therapeutic Targets: Identification of Novel Tumor Markers in Chronic Lymphocytic Leukemia
Cited by 2
Semantic Scholar
Small Leucine Rich Proteoglycans as Novel Tumor Markers In Chronic Lymphocytic Leukemia
Cited by 2
Semantic Scholar
Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells OA
Cited by 86
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(9)
Glycosylation and Glycoproteins Research
(5)
PI3K/AKT/mTOR signaling in cancer
(3)
Chronic Myeloid Leukemia Treatments
(3)
Galectins and Cancer Biology
(3)
Affiliations
Karolinska University Hospital
Karolinska Institutet
Tehran University of Medical Sciences